Trial
NCT02048904
Use of Sitagliptin to Decrease Microalbuminuria
Phase IVTERMINATEDOPERATIONALConfidence: HIGH
Sponsor
University of Missouri-Columbia
Collaborators
—
Condition
Type 2 Diabetes
Intervention
Sitagliptin
Why stopped
Original Principal Investigator left institution. No data analyzed.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2017-08-10